14 results
8-K
EX-99.2
AFIB
Acutus Medical Inc
12 Nov 21
Acutus Medical Reports Third Quarter 2021 Financial Results
5:16pm
are very actively looking across our investments, whether that's sales and marketing, R&D, critical corporate infrastructure, manufacturing, et-cetera
8-K
EX-99.1
AFIB
Acutus Medical Inc
12 Aug 21
Acutus Medical Reports Second Quarter 2021 Financial Results
4:09pm
, we are making great progress advancing several high priority R&D programs as well as clinical trials and regulatory approvals, including
10-K
2020 FY
AFIB
Acutus Medical Inc
19 Mar 21
Annual report
12:00am
for the year in which the differences are expected to reverse, and net operating loss (“NOL”) carryforwards and research and development (“R&D”) tax credit … laws and rates applicable to the period in which the differences are expected to affect taxable income, and NOL carryforwards and R&D tax credit
8-K
EX-99.1
h9l5r8c 0wze8
12 Nov 20
Acutus Medical Reports Third Quarter 2020 Results
4:14pm
10-Q
vpy74
18 Sep 20
Quarterly report
5:16pm
8-K
EX-99.1
ved6e5demwjoggejl2if
17 Sep 20
Acutus Medical Reports Second Quarter 2020 Financial Results
4:16pm
424B4
3nas60
7 Aug 20
Prospectus supplement with pricing info
12:00am
S-1/A
j9vqzj 2h47a7m5
30 Jul 20
IPO registration (amended)
6:27am
S-1
z1ujf70wwuemxe8u
15 Jul 20
IPO registration
4:53pm
DRS/A
wuls3i grwtdu
29 Jun 20
Draft registration statement (amended)
12:00am
DRS
sdiwrw1yi
15 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next